170 related articles for article (PubMed ID: 37534654)
61. Clinical and genetic signatures of local recurrence in oral squamous cell carcinoma.
Ghantous Y; Bahouth Z; Abu El-Naaj I
Arch Oral Biol; 2018 Nov; 95():141-148. PubMed ID: 30118965
[TBL] [Abstract][Full Text] [Related]
62. The mutational spectrum in whole exon of p53 in oral squamous cell carcinoma and its clinical implications.
Hyodo T; Kuribayashi N; Fukumoto C; Komiyama Y; Shiraishi R; Kamimura R; Sawatani Y; Yaguchi E; Hasegawa T; Izumi S; Wakui T; Nakashiro KI; Uchida D; Kawamata H
Sci Rep; 2022 Dec; 12(1):21695. PubMed ID: 36522371
[TBL] [Abstract][Full Text] [Related]
63. Whole genome duplication in oral squamous cell carcinoma in patients younger than 50 years: implications for prognosis and adverse clinicopathological factors.
Satgunaseelan L; Strbenac D; Willet C; Chew T; Sadsad R; Wykes J; Low TH; Cooper WA; Lee CS; Palme CE; Yang JYH; Clark JR; Gupta R
Genes Chromosomes Cancer; 2022 Sep; 61(9):561-571. PubMed ID: 35670448
[TBL] [Abstract][Full Text] [Related]
64. Promoter hypermethylation using 24-gene array in early head and neck cancer: better outcome in oral than in oropharyngeal cancer.
Noorlag R; van Kempen PM; Moelans CB; de Jong R; Blok LE; Koole R; Grolman W; van Diest PJ; van Es RJ; Willems SM
Epigenetics; 2014 Sep; 9(9):1220-7. PubMed ID: 25147921
[TBL] [Abstract][Full Text] [Related]
65. Combined mutational analysis of RAS, BRAF, PIK3CA, and TP53 genes in Taiwanese patients with oral squamous cell carcinoma.
Chang YS; Hsu HT; Ko YC; Yeh KT; Chang SJ; Lin CY; Chang JG
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Jul; 118(1):110-116.e1. PubMed ID: 24908601
[TBL] [Abstract][Full Text] [Related]
66. Integrative genomic and functional analysis of human oral squamous cell carcinoma cell lines reveals synergistic effects of FAT1 and CASP8 inactivation.
Hayes TF; Benaich N; Goldie SJ; Sipilä K; Ames-Draycott A; Cai W; Yin G; Watt FM
Cancer Lett; 2016 Dec; 383(1):106-114. PubMed ID: 27693639
[TBL] [Abstract][Full Text] [Related]
67. Exome sequencing of oral squamous cell carcinoma in users of Arabian snuff reveals novel candidates for driver genes.
Al-Hebshi NN; Li S; Nasher AT; El-Setouhy M; Alsanosi R; Blancato J; Loffredo C
Int J Cancer; 2016 Jul; 139(2):363-72. PubMed ID: 26934577
[TBL] [Abstract][Full Text] [Related]
68. Genetic Cross-Talk between Oral Squamous Cell Carcinoma and Type 2 Diabetes: The Potential Role of Immunity.
Fan Y; Zhang J; Shi J; Chen L; Long J; Zhang S; Liu S
Dis Markers; 2022; 2022():6389906. PubMed ID: 35634436
[TBL] [Abstract][Full Text] [Related]
69. Noninvasive genomic profiling of somatic mutations in oral cavity cancers.
Xi Y; Negrao MV; Akagi K; Xiao W; Jiang B; Warner SC; Dunn JD; Wang J; Symer DE; Gillison ML
Oral Oncol; 2023 May; 140():106372. PubMed ID: 37004423
[TBL] [Abstract][Full Text] [Related]
70. Hereditary oral squamous cell carcinoma associated with CDKN2A germline mutation: a case report.
Jeong AR; Forbes K; Orosco RK; Cohen EEW
J Otolaryngol Head Neck Surg; 2022 Feb; 51(1):5. PubMed ID: 35123577
[TBL] [Abstract][Full Text] [Related]
71. The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage.
Pannone G; Santoro A; Feola A; Bufo P; Papagerakis P; Lo Muzio L; Staibano S; Ionna F; Longo F; Franco R; Aquino G; Contaldo M; De Maria S; Serpico R; De Rosa A; Rubini C; Papagerakis S; Giovane A; Tombolini V; Giordano A; Caraglia M; Di Domenico M
Curr Cancer Drug Targets; 2014; 14(2):115-27. PubMed ID: 24274398
[TBL] [Abstract][Full Text] [Related]
72. Analysis of primary oral and oropharyngeal squamous cell carcinoma in inhabitants of Beijing, China-a 10-year continuous single-center study.
Bai XX; Zhang J; Wei L
BMC Oral Health; 2020 Jul; 20(1):208. PubMed ID: 32680501
[TBL] [Abstract][Full Text] [Related]
73. Gain of hTERC: a genetic marker of malignancy in oral potentially malignant lesions.
Dorji T; Monti V; Fellegara G; Gabba S; Grazioli V; Repetti E; Marcialis C; Peluso S; Di Ruzza D; Neri F; Foschini MP
Hum Pathol; 2015 Sep; 46(9):1275-81. PubMed ID: 26170010
[TBL] [Abstract][Full Text] [Related]
74. Identifying Drug Targets of Oral Squamous Cell Carcinoma through a Systems Biology Method and Genome-Wide Microarray Data for Drug Discovery by Deep Learning and Drug Design Specifications.
Lin YC; Chen BS
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142321
[TBL] [Abstract][Full Text] [Related]
75. Hypermethylated PAX1 and ZNF582 genes in the tissue sample are associated with aggressive progression of oral squamous cell carcinoma.
Sun R; Juan YC; Su YF; Zhang WB; Yu Y; Yang HY; Yu GY; Peng X
J Oral Pathol Med; 2020 Sep; 49(8):751-760. PubMed ID: 32428271
[TBL] [Abstract][Full Text] [Related]
76. Common and complex Notch1 mutations in Chinese oral squamous cell carcinoma.
Song X; Xia R; Li J; Long Z; Ren H; Chen W; Mao L
Clin Cancer Res; 2014 Feb; 20(3):701-10. PubMed ID: 24277457
[TBL] [Abstract][Full Text] [Related]
77. Role of epigenetics in OSCC: an understanding above genetics.
Vatsa PP; Jindal Y; Bhadwalkar J; Chamoli A; Upadhyay V; Mandoli A
Med Oncol; 2023 Mar; 40(4):122. PubMed ID: 36941511
[TBL] [Abstract][Full Text] [Related]
78. Prognostic significance of TP53 mutations in oral squamous cell carcinoma with human papilloma virus infection.
Kozomara RJ; Brankovic-Magic MV; Jovic NR; Stosic SM; Magic ZM
Int J Biol Markers; 2007; 22(4):252-7. PubMed ID: 18161655
[TBL] [Abstract][Full Text] [Related]
79. Droplet digital polymerase chain reaction for detection and quantification of cell-free DNA TP53 target somatic mutations in oral cancer.
Lin LH; Cheng HW; Liu CJ
Cancer Biomark; 2022; 33(1):29-41. PubMed ID: 34366328
[TBL] [Abstract][Full Text] [Related]
80. Whole-exome sequencing of transforming oral lichen planus reveals mutations in DNA damage repair and apoptosis pathway genes.
Xie F; Gleue CA; Deschaine M; Dasari S; Lau JS; Sartori-Valinotti JC; Meves A; Lehman JS
J Oral Pathol Med; 2022 Apr; 51(4):395-404. PubMed ID: 35146808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
